サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1612849

デジタルパソロジーの世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)

Digital Pathology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 177 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
デジタルパソロジーの世界市場：産業分析・規模・シェア・成長・動向・予測 (2024-2031年)
出版日: 2024年12月11日
発行: Persistence Market Research
ページ情報: 英文 177 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

主な洞察

  • デジタルパソロジーの市場規模 (2024年)：80億5,000万米ドル
  • 市場規模の予測 (2031年)：172億米ドル
  • 世界の市場成長率 (2024～2031年)：CAGR 13.5%

市場成長の促進要因：

世界のデジタルパソロジーの市場は、画像技術の進歩、慢性疾患の有病率の増加、遠隔医療や遠隔診断の採用拡大など、いくつかの重要な要因によって牽引されています。デジタルパソロジーソリューションは、より迅速、正確、効率的な診断プロセスを提供し、医療プロバイダーが患者の転帰を改善することを可能にします。デジタルパソロジーシステムにおけるAIと機械学習 (ML) の統合が診断精度とワークフロー効率を高めています。また、デジタルヘルス技術への投資の増加と医療インフラの改善に対する需要も市場の成長を促進しています。

市場抑制要因：

デジタルパソロジー市場は、確実な成長基調でありますが、機器の初期投資コストの高さ、既存の医療システムとの統合の複雑さ、データのプライバシーとセキュリティに関する懸念などの課題にも直面しています。また、発展途上地域におけるデジタルパソロジーソリューションの導入は、高度な医療技術へのアクセスが限られていることや、熟練した専門家の不足によって妨げられています。世界市場でデジタルパソロジーソリューションの可能性を最大限に引き出すためには、これらの障壁に対処する必要があります。

市場機会：

同市場では、技術の進歩、医療支出の増加、個別化医療の拡大が大きな成長機会を示しています。クラウドベースのプラットフォーム、AI主導の診断、画像診断技術の向上などの統合が新たな成長の道を示しています。また、分子診断、医薬品開発、研究用途に対する需要の高まりも、デジタルパソロジーソリューションに大きな事業機会をもたらしています。また、主要参入企業、研究機関、医療プロバイダー間のコラボレーションは、デジタルパソロジー技術の採用を進める上で重要な役割を果たしています。

当レポートでは、世界のデジタルパソロジーの市場を調査し、市場の定義と概要、市場促進要因・抑制要因、各種動向、市場機会、課題、市場規模 (金額・一部数量) の推移・予測、各種区分・地域/主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
    • 主な動向
  • マクロ経済要因
    • 世界のセクター別展望
    • 世界のGDP成長見通し
  • COVID-19の影響分析
  • 予測要因：関連性と影響

第3章 付加価値の洞察

  • 製品採用分析
  • 規制状況
  • バリューチェーン分析
  • 主要な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析
  • 親市場の分析

第4章 価格動向分析

  • 主なハイライト
  • 製品価格に影響を与える主な要因
  • 価格分析 (タイプ別)
  • 地域別の価格と製品の好み

第5章 世界のデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
    • 市場規模の予測
    • 市場規模・前年比成長率
    • 収益機会
  • 市場規模の分析・予測
  • 世界のデジタルパソロジー市場の展望：製品別
    • 市場規模の推移
    • 市場規模の予測
    • 市場の魅力分析：製品
  • 世界のデジタルパソロジー市場の展望：用途別
    • 市場規模の推移
    • 市場規模の予測
    • 市場の魅力分析：製品
  • 世界のデジタルパソロジー市場の展望：エンドユーザー別
    • 市場規模の推移
    • 市場規模の予測
    • 市場の魅力分析：製品

第6章 世界のデジタルパソロジー市場の展望：地域別

  • 主なハイライト
  • 市場規模の推移
  • 市場規模の予測
    • 北米
    • 欧州
    • 東アジア
    • 南アジア・オセアニア
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力分析：地域

第7章 北米のデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
    • 国別
    • 製品別
    • 用途別
    • エンドユーザー別
  • 市場規模の分析・予測：国別
    • 米国
    • カナダ
  • 市場規模の分析・予測：製品別
    • デジタルパソロジー機器
    • デジタルパソロジーソフトウェア
  • 市場規模の分析・予測：用途別
    • 臨床病理
    • 分子診断
    • 基礎研究・応用研究
    • 医薬品開発
    • その他
  • 市場規模の分析・予測：エンドユーザー別
    • 病院
    • 診断ラボ
    • 製薬・バイオテクノロジー企業
    • 法医学研究所
    • 研究機関
    • CRO
    • クリニック
  • 市場の魅力分析

第8章 欧州のデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
  • 市場規模の分析・予測：国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • トルコ
    • その他
  • 市場規模の分析・予測：製品別
  • 市場規模の分析・予測：用途別
  • 市場規模の分析・予測：エンドユーザー別
  • 市場の魅力分析

第9章 東アジアのデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
  • 市場規模の分析・予測：国別
    • 中国
    • 日本
    • 韓国
  • 市場規模の分析・予測：製品別
  • 市場規模の分析・予測：用途別
  • 市場規模の分析・予測：エンドユーザー別
  • 市場の魅力分析

第10章 南アジア・オセアニアのデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
  • 市場規模の分析・予測：国別
    • インド
    • 東南アジア
    • オーストラリア
    • その他
  • 市場規模の分析・予測：製品別
  • 市場規模の分析・予測：用途別
  • 市場規模の分析・予測：エンドユーザー別
  • 市場の魅力分析

第11章 ラテンアメリカのデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
  • 市場規模の分析・予測：国別
    • ブラジル
    • メキシコ
    • その他
  • 市場規模の分析・予測：製品別
  • 市場規模の分析・予測：用途別
  • 市場規模の分析・予測：エンドユーザー別
  • 市場の魅力分析

第12章 中東・アフリカのデジタルパソロジー市場の展望：推移・予測

  • 主なハイライト
  • 価格分析
  • 市場規模の推移
  • 市場規模の分析・予測：国別
    • GCC諸国
    • エジプト
    • 南アフリカ
    • 北アフリカ
    • その他
  • 市場規模の分析・予測：製品別
  • 市場規模の分析・予測：用途別
  • 市場規模の分析・予測：エンドユーザー別
  • 市場の魅力分析

第13章 競合情勢

  • 市場シェア分析
  • 市場構造
  • 企業プロファイル (詳細：概要、財務、戦略、最近の動向)
    • Leica Biosystems (Danaher Corporation)
    • F. Hoffmann-La Roche AG
    • Huron Technologies International Inc.
    • Koninklijke Philips N.V.
    • Olympus Corporation
    • Hamamatsu Photonics K.K.
    • Carl Zeiss AG
    • Nikon Corporation
    • 3DHISTECH Ltd.
    • Hologic Inc.
    • PerkinElmer, Inc.
    • Visiopharm
    • OptraSCAN, Inc.
    • Inspirata, Inc.

第14章 付録

目次
Product Code: PMRREP33922

Persistence Market Research has recently released a comprehensive report on the global Digital Pathology Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Digital Pathology Market Size (2024E): USD 8.05 Bn
  • Projected Market Value (2031F): USD 17.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 13.5%

Digital Pathology Market - Report Scope:

Digital pathology refers to the acquisition, management, sharing, and interpretation of pathology information in a digital environment. The market includes various products and services, such as digital pathology equipment, software, and services, that enable the transformation of traditional microscopy and pathology workflows. The growing adoption of digital pathology solutions is driven by factors such as the increasing demand for accurate diagnostics, advancements in telepathology, and the need for efficient and scalable pathology systems in clinical, research, and pharmaceutical settings.

Market Growth Drivers:

The global digital pathology market is driven by several key factors, including advancements in imaging technology, the increasing prevalence of chronic diseases, and the growing adoption of telemedicine and remote diagnostics. Digital pathology solutions provide faster, more accurate, and more efficient diagnostic processes, enabling healthcare providers to improve patient outcomes. The integration of artificial intelligence (AI) and machine learning (ML) in digital pathology systems is enhancing diagnostic accuracy and workflow efficiency. Additionally, increasing investments in digital health technologies and the demand for improved healthcare infrastructure are fueling market growth.

Market Restraints:

Despite its promising growth, the digital pathology market faces challenges such as high initial investment costs for equipment, integration complexities with existing healthcare systems, and concerns about data privacy and security. Additionally, the adoption of digital pathology solutions in developing regions is hindered by limited access to advanced healthcare technologies and a lack of skilled professionals. These barriers need to be addressed to unlock the full potential of digital pathology solutions in global markets.

Market Opportunities:

The market presents significant growth opportunities driven by advancements in technology, increased healthcare spending, and the expansion of personalized medicine. The integration of cloud-based platforms, AI-driven diagnostics, and improved imaging techniques offers new avenues for growth. Moreover, the rising demand for molecular diagnostics, drug development, and research applications presents substantial opportunities for digital pathology solutions. Collaborations between key market players, research institutes, and healthcare providers will play a crucial role in advancing the adoption of digital pathology technologies.

Key Questions Answered in the Report:

  • What are the primary factors driving the global growth of the digital pathology market?
  • Which types of digital pathology products are witnessing the highest adoption across different regions?
  • How is the integration of AI and machine learning transforming the digital pathology landscape?
  • Who are the leading players in the digital pathology market, and what strategies are they employing to remain competitive?
  • What are the emerging trends and future prospects in the digital pathology market?

Competitive Intelligence and Business Strategy:

Leading players in the global digital pathology market, such as Danaher Corporation, F. Hoffmann-La Roche AG, and Koninklijke Philips N.V., are focusing on product innovation, strategic partnerships, and acquisitions to maintain their market leadership. These companies are investing heavily in research and development to create advanced digital pathology solutions that integrate AI, machine learning, and cloud technologies. Collaboration with healthcare providers, research institutes, and regulatory bodies is essential for market expansion and adoption. Furthermore, improving the interoperability of digital pathology systems with existing healthcare IT infrastructure is a key strategy for long-term growth.

Key Companies Profiled:

  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • Huron Technologies International Inc.
  • Koninklijke Philips N.V.
  • Olympus Corporation
  • Hamamatsu Photonics K.K.
  • Carl Zeiss AG
  • Nikon Corporation
  • 3DHISTECH Ltd.
  • Hologic Inc.
  • PerkinElmer, Inc.
  • Visiopharm

Digital Pathology Industry Research by Category:

By Product Type:

  • Digital Pathology Equipment
  • Digital Pathology Software
  • Digital Pathology Services

By Application:

  • Clinical Pathology
  • Molecular Diagnostics
  • Basic and Applied Research
  • Drug Development
  • Others

By End User:

  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Forensic Laboratories
  • Research Institutes
  • Contract Research Organizations (CROs)
  • Clinics

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • The Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Digital Pathology Market Snapshot, 2024 - 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Analysis
  • 3.7. Parent Market Analysis

4. Price Analysis, 2023A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Digital Pathology Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
      • 5.3.3.1. Digital Pathology Equipment
        • 5.3.3.1.1. Whole Slide Scanners
        • 5.3.3.1.1.1. Brightfield Slide Scanners
        • 5.3.3.1.1.2. Fluorescence Slide Scanners
        • 5.3.3.1.1.3. Combination Slide Scanners
        • 5.3.3.1.2. Clinical Microscope
        • 5.3.3.1.3. Tissue Microarrays
      • 5.3.3.2. Digital Pathology Software
        • 5.3.3.2.1. Image Viewing and Analysis Software
        • 5.3.3.2.2. Digital Pathology Information Systems
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Digital Pathology Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
      • 5.4.3.1. Clinical Pathology
      • 5.4.3.2. Molecular Diagnostics
      • 5.4.3.3. Basic & Applied Research
      • 5.4.3.4. Drug Development
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Digital Pathology Market Outlook: End User
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Diagnostic Laboratories
      • 5.5.3.3. Pharmaceutical & Biotechnology Companies
      • 5.5.3.4. Forensic Laboratories
      • 5.5.3.5. Research Institutes
      • 5.5.3.6. Contract Research Organizations (CROs)
      • 5.5.3.7. Clinics
    • 5.5.4. Market Attractiveness Analysis: End User

6. Global Digital Pathology Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 7.4.1. Digital Pathology Equipment
      • 7.4.1.1. Whole Slide Scanners
        • 7.4.1.1.1. Brightfield Slide Scanners
        • 7.4.1.1.2. Fluorescence Slide Scanners
        • 7.4.1.1.3. Combination Slide Scanners
      • 7.4.1.2. Clinical Microscope
      • 7.4.1.3. Tissue Microarrays
    • 7.4.2. Digital Pathology Software
      • 7.4.2.1. Image Viewing and Analysis Software
      • 7.4.2.2. Digital Pathology Information Systems
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 7.5.1. Clinical Pathology
    • 7.5.2. Molecular Diagnostics
    • 7.5.3. Basic & Applied Research
    • 7.5.4. Drug Development
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic Laboratories
    • 7.6.3. Pharmaceutical & Biotechnology Companies
    • 7.6.4. Forensic Laboratories
    • 7.6.5. Research Institutes
    • 7.6.6. Contract Research Organizations (CROs)
    • 7.6.7. Clinics
  • 7.7. Market Attractiveness Analysis

8. Europe Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 8.4.1. Digital Pathology Equipment
      • 8.4.1.1. Whole Slide Scanners
        • 8.4.1.1.1. Brightfield Slide Scanners
        • 8.4.1.1.2. Fluorescence Slide Scanners
        • 8.4.1.1.3. Combination Slide Scanners
      • 8.4.1.2. Clinical Microscope
      • 8.4.1.3. Tissue Microarrays
    • 8.4.2. Digital Pathology Software
      • 8.4.2.1. Image Viewing and Analysis Software
      • 8.4.2.2. Digital Pathology Information Systems
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 8.5.1. Clinical Pathology
    • 8.5.2. Molecular Diagnostics
    • 8.5.3. Basic & Applied Research
    • 8.5.4. Drug Development
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic Laboratories
    • 8.6.3. Pharmaceutical & Biotechnology Companies
    • 8.6.4. Forensic Laboratories
    • 8.6.5. Research Institutes
    • 8.6.6. Contract Research Organizations (CROs)
    • 8.6.7. Clinics
  • 8.7. Market Attractiveness Analysis

9. East Asia Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 9.4.1. Digital Pathology Equipment
      • 9.4.1.1. Whole Slide Scanners
        • 9.4.1.1.1. Brightfield Slide Scanners
        • 9.4.1.1.2. Fluorescence Slide Scanners
        • 9.4.1.1.3. Combination Slide Scanners
      • 9.4.1.2. Clinical Microscope
      • 9.4.1.3. Tissue Microarrays
    • 9.4.2. Digital Pathology Software
      • 9.4.2.1. Image Viewing and Analysis Software
      • 9.4.2.2. Digital Pathology Information Systems
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 9.5.1. Clinical Pathology
    • 9.5.2. Molecular Diagnostics
    • 9.5.3. Basic & Applied Research
    • 9.5.4. Drug Development
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic Laboratories
    • 9.6.3. Pharmaceutical & Biotechnology Companies
    • 9.6.4. Forensic Laboratories
    • 9.6.5. Research Institutes
    • 9.6.6. Contract Research Organizations (CROs)
    • 9.6.7. Clinics
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 10.4.1. Digital Pathology Equipment
      • 10.4.1.1. Whole Slide Scanners
        • 10.4.1.1.1. Brightfield Slide Scanners
        • 10.4.1.1.2. Fluorescence Slide Scanners
        • 10.4.1.1.3. Combination Slide Scanners
      • 10.4.1.2. Clinical Microscope
      • 10.4.1.3. Tissue Microarrays
    • 10.4.2. Digital Pathology Software
      • 10.4.2.1. Image Viewing and Analysis Software
      • 10.4.2.2. Digital Pathology Information Systems
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 10.5.1. Clinical Pathology
    • 10.5.2. Molecular Diagnostics
    • 10.5.3. Basic & Applied Research
    • 10.5.4. Drug Development
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic Laboratories
    • 10.6.3. Pharmaceutical & Biotechnology Companies
    • 10.6.4. Forensic Laboratories
    • 10.6.5. Research Institutes
    • 10.6.6. Contract Research Organizations (CROs)
    • 10.6.7. Clinics
  • 10.7. Market Attractiveness Analysis

11. Latin America Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 11.4.1. Digital Pathology Equipment
      • 11.4.1.1. Whole Slide Scanners
        • 11.4.1.1.1. Brightfield Slide Scanners
        • 11.4.1.1.2. Fluorescence Slide Scanners
        • 11.4.1.1.3. Combination Slide Scanners
      • 11.4.1.2. Clinical Microscope
      • 11.4.1.3. Tissue Microarrays
    • 11.4.2. Digital Pathology Software
      • 11.4.2.1. Image Viewing and Analysis Software
      • 11.4.2.2. Digital Pathology Information Systems
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 11.5.1. Clinical Pathology
    • 11.5.2. Molecular Diagnostics
    • 11.5.3. Basic & Applied Research
    • 11.5.4. Drug Development
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic Laboratories
    • 11.6.3. Pharmaceutical & Biotechnology Companies
    • 11.6.4. Forensic Laboratories
    • 11.6.5. Research Institutes
    • 11.6.6. Contract Research Organizations (CROs)
    • 11.6.7. Clinics
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Digital Pathology Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End User
  • 12.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024 - 2031
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2024 - 2031
    • 12.4.1. Digital Pathology Equipment
      • 12.4.1.1. Whole Slide Scanners
        • 12.4.1.1.1. Brightfield Slide Scanners
        • 12.4.1.1.2. Fluorescence Slide Scanners
        • 12.4.1.1.3. Combination Slide Scanners
      • 12.4.1.2. Clinical Microscope
      • 12.4.1.3. Tissue Microarrays
    • 12.4.2. Digital Pathology Software
      • 12.4.2.1. Image Viewing and Analysis Software
      • 12.4.2.2. Digital Pathology Information Systems
  • 12.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024 - 2031
    • 12.5.1. Clinical Pathology
    • 12.5.2. Molecular Diagnostics
    • 12.5.3. Basic & Applied Research
    • 12.5.4. Drug Development
    • 12.5.5. Others
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2024 - 2031
    • 12.6.1. Hospitals
    • 12.6.2. Diagnostic Laboratories
    • 12.6.3. Pharmaceutical & Biotechnology Companies
    • 12.6.4. Forensic Laboratories
    • 12.6.5. Research Institutes
    • 12.6.6. Contract Research Organizations (CROs)
    • 12.6.7. Clinics
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Leica Biosystems (Danaher Corporation)
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. F. Hoffmann-La Roche AG
    • 13.3.3. Huron Technologies International Inc.
    • 13.3.4. Koninklijke Philips N.V.
    • 13.3.5. Olympus Corporation
    • 13.3.6. Hamamatsu Photonics K.K.
    • 13.3.7. Carl Zeiss AG
    • 13.3.8. Nikon Corporation
    • 13.3.9. 3DHISTECH Ltd.
    • 13.3.10. Hologic Inc.
    • 13.3.11. PerkinElmer, Inc.
    • 13.3.12. Visiopharm
    • 13.3.13. OptraSCAN, Inc.
    • 13.3.14. Inspirata, Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations